scholarly journals A sensitive and specific point-of-care detection assay for Zaire Ebola virus

2017 ◽  
Vol 6 (1) ◽  
pp. 1-3 ◽  
Author(s):  
Xiao-Ai Zhang ◽  
Sabrina Li ◽  
Jesus Ching ◽  
Hui-Ying Feng ◽  
Kun Yang ◽  
...  
Nanoscale ◽  
2019 ◽  
Vol 11 (34) ◽  
pp. 16026-16035 ◽  
Author(s):  
Liang Huang ◽  
Jiening Jin ◽  
Jing Wang ◽  
Chenxing Jiang ◽  
Meng Xu ◽  
...  

Sensitive and specific point-of-care detection of methamphetamine in urine was achieved using novel structured gold nano-labels for signal amplification.


PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e51685 ◽  
Author(s):  
Deborah Dean ◽  
Rosemary S. Turingan ◽  
Hans-Ulrich Thomann ◽  
Anna Zolotova ◽  
James Rothschild ◽  
...  

2016 ◽  
Vol 214 (suppl 3) ◽  
pp. S234-S242 ◽  
Author(s):  
Jason W. Benzine ◽  
Kerry M. Brown ◽  
Krystle N. Agans ◽  
Ronald Godiska ◽  
Chad E. Mire ◽  
...  

2020 ◽  
Vol 98 ◽  
pp. 262-268
Author(s):  
Ravina ◽  
Anita Dalal ◽  
Paramjeet Singh Gill ◽  
Jagriti Narang ◽  
Minakshi Prasad ◽  
...  

2022 ◽  
Vol 16 (1) ◽  
pp. e0010112
Author(s):  
Sirawit Jirawannaporn ◽  
Umaporn Limothai ◽  
Sasipha Tachaboon ◽  
Janejira Dinhuzen ◽  
Patcharakorn Kiatamornrak ◽  
...  

Background One of the key barriers preventing rapid diagnosis of leptospirosis is the lack of available sensitive point-of-care testing. This study aimed to develop and validate a clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 12a (CRISPR/Cas12a) platform combined with isothermal amplification to detect leptospires from extracted patient DNA samples. Methodology/Principal findings A Recombinase Polymerase Amplification (RPA)-CRISPR/Cas12a-fluorescence assay was designed to detect the lipL32 gene of pathogenic Leptospira spp. The assays demonstrated a limit of detection (LOD) of 100 cells/mL, with no cross-reactivity against several other acute febrile illnesses. The clinical performance of the assay was validated with DNA extracted from 110 clinical specimens and then compared to results from qPCR detection of Leptospira spp. The RPA-CRISPR/Cas12a assay showed 85.2% sensitivity, 100% specificity, and 92.7% accuracy. The sensitivity increased on days 4–6 after the fever onset and decreased after day 7. The specificity was consistent for several days after the onset of fever. The overall performance of the RPA-CRISPR/Cas12a platform was better than the commercial rapid diagnostic test (RDT). We also developed a lateral flow detection assay (LFDA) combined with RPA-CRISPR/Cas12a to make the test more accessible and easier to interpret. The combined LFDA showed a similar LOD of 100 cells/mL and could correctly distinguish between known positive and negative clinical samples in a pilot study. Conclusions/Significance The RPA-CRISPR/Cas12 targeting the lipL32 gene demonstrated acceptable sensitivity and excellent specificity for detection of leptospires. This assay might be an appropriate test for acute leptospirosis screening in limited-resource settings.


2017 ◽  
Vol 89 (24) ◽  
pp. 13105-13111 ◽  
Author(s):  
Jiao Hu ◽  
Yong-Zhong Jiang ◽  
Ling-Ling Wu ◽  
Zhen Wu ◽  
Yuhai Bi ◽  
...  

2021 ◽  
Vol 22 (1) ◽  
pp. 456
Author(s):  
Simone Rentschler ◽  
Lars Kaiser ◽  
Hans-Peter Deigner

Precise and rapid identification and characterization of pathogens and antimicrobial resistance patterns are critical for the adequate treatment of infections, which represent an increasing problem in intensive care medicine. The current situation remains far from satisfactory in terms of turnaround times and overall efficacy. Application of an ineffective antimicrobial agent or the unnecessary use of broad-spectrum antibiotics worsens the patient prognosis and further accelerates the generation of resistant mutants. Here, we provide an overview that includes an evaluation and comparison of existing tools used to diagnose bacterial infections, together with a consideration of the underlying molecular principles and technologies. Special emphasis is placed on emerging developments that may lead to significant improvements in point of care detection and diagnosis of multi-resistant pathogens, and new directions that may be used to guide antibiotic therapy.


Sign in / Sign up

Export Citation Format

Share Document